Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06694857 · ClinicalTrials.gov registry record · Phase 4
A Prospective Evaluation of the Filler for Jaw Contouring
A Phase 4 study of Dermal Fillers, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT06694857 is a Phase 4 study of Dermal Fillers that has completed, run by University of Pennsylvania. The registered enrollment target is 14 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06694857, a Phase 4 study of Dermal Fillers, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days. The main question it aims to answer is: To quantify volume change of the lower face area over time after injection of filler * Participants will receive hyaluronic acid filler injections (Juvéderm Volux XC) for contouring of the jawline. Each patient will receive FDA approved dosages of filler to the lower face region to treat facial contour or asymmetry, as per FDA approved indications. * Prior to injection patients will be imaged with 3-dimensional photogrammetry. Subjects will return post-injection in 2 weeks, 1 month, and 3 months for re-imaging.
Conditions Studied
Interventions
- DRUG HA filler
Study Locations (1)
Pennsylvania
- Penn Medicine - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-10-31 |
| Est. Completion | 2025-11-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06694857
The ClinicalTrials.gov registry entry for NCT06694857 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dermal Fillers appearing as the primary indexed condition, and to 1 intervention - of which HA filler is the first listed.
NCT06694857 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06694857 about?
NCT06694857 is a clinical study titled "A Prospective Evaluation of the Filler for Jaw Contouring". The goal of this prospective study is to analyze volumetric changes in the lower face after hyaluronic acid filler injections over 90 days. The main question it aims to answer is: To quantify volume change of the lower face area over time after injection of filler * Participants will receive hyalu...
What is the current status of trial NCT06694857?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2024-10-31. Estimated completion is 2025-11-01.
What conditions does trial NCT06694857 study?
This clinical trial studies the following conditions: Dermal Fillers.
What interventions are being tested in trial NCT06694857?
The interventions under investigation include: HA filler (DRUG).
Who is sponsoring clinical trial NCT06694857?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06694857 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.